CLASS III ONGOING Drug recall · Reported 12 Jun 2024 · FDA Enforcement Report

Cephalexin for Oral Suspension, USP, 125mg recalled

Bryant Ranch Prepack is recalling Cephalexin for Oral Suspension, USP, 125mg per, distributed nationwide in the US. The recall was initiated on 10 May 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot:234892, Exp:02/28/2025.
NDC63629-9205
Quantity recalled6 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0537-2024
FDA event ID
94605
Recalling firm
Bryant Ranch Prepack, Burbank, CA
Manufacturer
Bryant Ranch Prepack
Classification
Class III
Status
Ongoing
Recall initiated
10 May 2024
FDA classified
4 Jun 2024
Reported
12 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antibiotics

Timeline

10 May 2024Recall initiated by company
4 Jun 2024Classified by FDA+25 days
12 Jun 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified: Back label states Each contains: cephalexin monohydrate, USP equivalent to 2.5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g

Product as listed by the FDA

Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 200mL (when mixed), Each contains: cephalexin monohydrate, USP equivalent to 2.5g of cephalexin in a strawberry flavored mixture. Manufactured by Alkem Laboratories Ltd, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9205-1.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is Cephalexin for Oral Suspension, USP, 125mg per recalled?

Yes. Bryant Ranch Prepack recalled Cephalexin for Oral Suspension, USP, 125mg per on 10 May 2024. The recall is Class III and its status is Ongoing. Recall number D-0537-2024.

Why was it recalled?

Labeling: Not Elsewhere Classified: Back label states Each contains: cephalexin monohydrate, USP equivalent to 2.5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g

Which lots are affected?

Lot:234892, Exp:02/28/2025.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bryant Ranch Prepack

All 17
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIICephalexin for Oral Suspension, USP, 125mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIICephalexin for Oral Suspension, USP, 250mg recalledCephalexinBryant Ranch PrepackOtherNationwide
DrugCLASS IIILidocaine Patch 5%, 1 patch (63629-8755-20) recalledLidocaineBryant Ranch PrepackPackaging DefectsNationwide

Other Cephalexin recalls

All 19